Bausch + Lomb Corporation (BLCO) is a publicly traded company in the Healthcare — Medical - Instruments & Supplies industry listed on NYSE. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
Bausch + Lomb Corporation is a leading global eye health company. Its operations are structured across three primary segments: Vision Care/Consumer Health, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health division offers a comprehensive portfolio of contact lenses, encompassing all wearing modalities from daily disposables to frequently replaced options.
Is Bausch + Lomb Corporation stock overvalued or undervalued in 2026?
As of October 30, 2026, Bausch + Lomb Corporation (BLCO) trades at $20.00 with no positive earnings over the last twelve months, according to Kaplio. No valuation verdict: it has no earnings to calculate a P/E from.
Kaplio overview: Bausch + Lomb Corporation
Market cap $7B · 52 weeks $15 – $20 (0 % below the high) · P/E no earnings · 2027 expected P/E 18.1× · Dividend none · Next earnings February 17, 2027 · expected EPS $0.33 · Closing price, Oct 30 · accounts published Oct 28.
- Valuation: EV/EBITDA 9.9× (no earnings).
- Business: ROIC 4 % (weak).
- Balance sheet: Net debt/EBITDA 9.3× (fragile).
- Earnings: 6 of 8 (on track).
What would it be worth at its usual multiples?
No valuation verdict: it has no earnings to calculate a P/E from.
What matters in pharma: 0 of 4 pass
- R&D / Revenue 7.3 %, fails.
- Gross margin 54.8 %, fails.
- ROIC 3.8 %, fails.
- Net debt / EBITDA 9.3×, fails.
Against its peers (reference peers) — Bausch + Lomb Corporation: P/E —; EV/EBITDA 9.9×; ROIC 3.8 %; $7.1B. Merit Medical Systems, Inc. (P/E 32.4×; EV/EBITDA 18.9×; ROIC -64.5 %; $5.1B), Oscar Health, Inc. (P/E 21.7×; EV/EBITDA 6.8×; ROIC 23.0 %; $7.9B), TG Therapeutics, Inc. (P/E 22.3×; EV/EBITDA 67.5×; ROIC 9.9 %; $9.4B).
Profitability
| Return on Equity | -1.73% |
| Return on Invested Capital | 3.78% |
| Return on Assets | -0.80% |
| Gross Margin | 58.62% |
| Operating Margin | 8.41% |
| Net Margin | -2.05% |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 1.56 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 0.89 |
Price Performance
| 1 month | +20.43% |
| 3 months | +20.64% |
| Year-to-date | +19.44% |
| 1 year | +36.55% |
| 3 years | +23.49% |
Related companies: ARWR · PCVX · PTCT · TGTX · CRSP · MMSI · GKOS
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of BLCO: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks